BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 17418482)

  • 21. TURP in patients with biopsy-proven prostate cancer: sensitivity for cancer detection.
    Bach T; Geavlete B; Pfeiffer D; Wendt-Nordahl G; Michel MS; Gross AJ
    Urology; 2009 Jan; 73(1):100-4. PubMed ID: 18718643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer.
    Puppo P; Introini C; Calvi P; Naselli A
    Eur Urol; 2006 May; 49(5):873-8. PubMed ID: 16439052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies.
    Philip J; Dutta Roy S; Scally J; Foster CS; Javlé P
    Prostate; 2005 Jul; 64(2):200-2. PubMed ID: 15712218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
    Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
    Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.
    Ghalayini IF; Al-Ghazo MA; Pickard RS
    BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar transurethral resection of prostate: clinical and urodynamic evaluation.
    Iori F; Franco G; Leonardo C; Laurenti C; Tubaro A; D-Amico F; Dini D; De Nunzio C
    Urology; 2008 Feb; 71(2):252-5. PubMed ID: 18308095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rising PSA in patients with minor LUTS without evidence of prostatic carcinoma: a missing link?
    van Renterghem K; Van Koeveringe G; Van Kerrebroeck P
    Int Urol Nephrol; 2007; 39(4):1107-13. PubMed ID: 17602307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Nomura H; Seki N; Yamaguchi A; Naito S
    Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application value of diagnostic TURP for patients with serum PSA abnormality].
    Yuan J; Zhao H; Wu B
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement.
    Seki N; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2006; 25(5):428-32. PubMed ID: 16721841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum prostate-specific antigen to predict the presence of bladder outlet obstruction in men with urinary symptoms.
    Laniado ME; Ockrim JL; Marronaro A; Tubaro A; Carter SS
    BJU Int; 2004 Dec; 94(9):1283-6. PubMed ID: 15610106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term results of transurethral vaporization of the prostate using plasmakinetic energy.
    Kaya C; Ilktac A; Gokmen E; Ozturk M; Karaman IM
    BJU Int; 2007 Apr; 99(4):845-8. PubMed ID: 17378844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
    Bozdar HR; Memon SR; Paryani JP
    J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.
    Suardi N; Scattoni V; Briganti A; Salonia A; Naspro R; Gallina A; Cestari A; Colombo R; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2008 Jun; 53(6):1180-5. PubMed ID: 17659829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
    Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
    Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.